Patented bioavailability enhancement techniques of silymarin

Recent Patents on Drug Delivery and Formulation

Volumn 4, Issue 2, 2010, Pages 145-152

  Javed, Shamama ^a   Kohli, Kanchan ^a   Ali, Mushir ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Bioavailability; Controlled; Delivery; Flavonolignans; Hepatic disorders; Herbal; Milk thistle; Phospholipids; Silybin; Silymarin; Solubility; Targeted

Indexed keywords

CYCLODEXTRIN; ESSENTIAL FATTY ACID; GLYCYRRHETINIC ACID PHOSPHOLIPID COMPLEX; LIPOSOME; MACROGOL; NANOPARTICLE; PHOSPHOLIPID; POLYPHENOL DERIVATIVE; POVIDONE; SILYMARIN; THIOCTIC ACID;

AREA UNDER THE CURVE; ARTICLE; COMPLEX FORMATION; CONTROLLED RELEASE FORMULATION; CRYSTAL STRUCTURE; DERMATITIS; DRUG ABSORPTION; DRUG ADMINISTRATION ROUTE; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG SAFETY; DRUG SOLUBILITY; DRUG TARGETING; DRUG TRANSFORMATION; DYSTROPHY; EMULSION; ERYTHEMA; FREEZE DRYING; HUMAN; MAXIMUM PLASMA CONCENTRATION; MOLECULAR INTERACTION; NONHUMAN; PARTICLE SIZE; PATENT; PRIORITY JOURNAL; PROSTATE DISEASE; SCALD; SILYBUM MARIANUM; SKIN DYSTROPHY; SPRAY DRYING; SUSTAINED RELEASE PREPARATION; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; DRUG DELIVERY SYSTEMS; HUMANS; MILK THISTLE; PATENTS AS TOPIC; PLANT EXTRACTS; PROTECTIVE AGENTS; SEEDS; SILYMARIN;

EID: 77954075760     PISSN: 18722113     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221110791184999     Document Type: Article

References (72)

1. Qazi, G.N., Bedi, K.L., Johri, R.K., Tikoo, M.K., Tikoo, A.K., Sharma, S.C., Absullah, S.T., Suri, O.P., Gupta, B.D., Suri, K.A., Satti, N.K., Khajuria, R.K., Singh, S., Khajuria, A., Kapahi, B.K. Bioavailability/ bioefficacy enhancing activity of Cuminum cyminum and extracts and fractions thereof. US20067070814 (2006).
2. Kren V, Walterova D. Silybin and silymarin - new effects and application. Biomed Pap 2005; 149: 29-41.
3. Loftsson, T. Cyclodextrin/drug complexation. US5324718 (1994).
4. Valcavi, U., Monterosso, V., Caponi, R., Bosone, E., Wachter, W., Szejtli, J. Inclusion complexes with silybinin, their preparation and pharmaceutical compositions containing them. US5198430 (1993).
5. Chang, S., Song, J. Solid dispersions containing substituted cyclodextrin and insoluble drug and their preparations. WO043602 (2003).
6. Bhattacharya S, Ghosh AK. Phytosomes: The emerging technology for enhancement of bioavailability of botanicals and nutraceuticals. Int J Aesthethic Antiaging Med 2009; 2.
7. Bombardelli, E., Magistretti, M.J. Pharmaceutical compositions containing flavanolignanes and phospholipids as active principles. EP0209037 (1987).
8. Gabetta, B., Bombardelli, E., Pifferi, G. Complexes of flavanolignans with phospholipids, preparation thereof and associated pharmaceutical compositions. US4764508 (1988).
9. Bombardelli, E. Pharmaceutical and cosmetic compositions containing complexes of flavanolignans with phospholipids. US4895839 (1990).
10. Bombardelli, E., Morazzoni, P. Pharmaceutical compositions containing flavanolignanes and methods for using same as an antiproliferative. US5912265 (1999).
11. Bombardelli, E., Morazzoni, P. Pharmaceutical compositions containing flavanolignanes and methods for using same as an antiproliferative. US6218369 (2001).
12. Bombardelli, E., Morazzzoni, P., Riva, A. Herbal compositions for the teatment and prevention of prostate disorders. US20060246153 (2006).
13. Yanyu X, Yunmei S, Zhipeng C, Qineng P. The preparation of silybin-phospholipid complex and the study on its pharmacokinetics in rats. Int J Pharm 2006; 307: 77-82.
14. Jiangnan Y., Shanshan, T., Yuan, Z., Xia, C., Ximing, X. Silymarin high-efficient long-acting preparation and production method thereof. CN101439025 (2009).
15. Li, S., Wang, Z., Guo, X. Hepadestal soft capsule and its preparing method. CN1586468 (2005).
16. Madaus, R.H.H., Halbach, G., Trost W. Salt of the silymarin group with aminopolyhydroxy alcohols. US3994925 (1976).
17. Giorgi, R., Conti, M., Pifferi, G. Soluble derivatives of silybin, a method of preparing them, and pharmaceutical compositions containing them. US4886791 (1989).
18. Ely, P.H. Antiinflammatory compositions and method of use. US5196448 (1993).
19. Rovati, L.C., D'amato, M.M., Mengs, U., Pohl, R.-T., Ferenci, P. Silibinin component for the treatment of hepatitis. WO2009062737 (2009).
20. Kosina P, Kren V, Gebhardt R, Grambal F, Ulrichová J, Walterová D. Antioxidant properties of silybin glycosides. Phytother Res 2002; 16(Suppl 1): 33-9.
21. Oslick, B.D., Barclay, D. Compositions for prevention and treatment of symptoms associated with ethyl alcohol consumption US20056967031 (2005).
22. Auriol, D., Nalin, R., Robe, P., Lefevre, F. Water soluble phenolics derivatives with dermocosmetic and therapeutic applications. EP1867729 (2007).
23. Li F-Q, Hu J-H. Improvement of the dissolution rate of silymarin by means of solid dispersions. Chem Pharm Bull 2004; 52: 972-3.
24. Oppenheim, R.C., Troung, H.C., Lin, J. Clear herbal extract solutions. WO9920289 (1999).
25. Bae, U.T., Jang, S.U., Kim J.H., Kwak, H.H., Kwon J.W., Wang, H.S. Pharmaceutical composition of flavonolignan for oral use using auto micellized drug delivery system. KR0082590 (2002).
26. Koo, C-H., Choi, D-Y., Song, Il-Y. Compositions and preparations of silymarin complex with the improved bioavailability. WO069962 (2002).
27. Robinson, L.R., Ha, R.B. Methods of enhancing delivery of oil-soluble skin care actives. US20020022040 (2002).
28. Coote, J.W., Wayne, M.D., Regtop, H.L., Biffin, J.R. Emulsion and dispersion formulations and method. US20040167034 (2004).
29. Gil, Y.S., Yu, C.H., Hong, S.C., Ahn, K.Y., Yang, G.W., Ahn, G.S., Choung, K.H. Silymarin-containing pharmaceutical composition and soft capsules containing the same. KR0002846 (2004).
30. Li, B. Water soluble silymarin and its prepn. CN101019859 (2007).
31. Shixia, G. Legalon pharmaceutical preparation and method for preparing the same. CN101108179 (2008).
32. Wachter, W., Zaeske, H. Process for the manufacture of flavanolignan preparations with improved release and absorbability, compositions obtainable thereby and their use for the preparation of pharmaceuticals. US5906991 (1999).
33. Wachter, W., Zaeske, H. Process for the manufacture of flavanolignan preparation with improved release and absorbability, compositions obtainable thereby and their use for the preparation of pharmaceuticals. US0020384 (2000).
34. Feng, J., Lu, W., He, J. Silymarin nano granular preparation and process for preparing the same. CN1463700 (2003).
35. Feng, J., Lu, W., He, J. Silymarin behenic acid glyceride lipid nano particle oral solution dosage and its preparation method. CN1493278 (2004).
36. Bae, J.H., Lee, J.H., Lee, H., Kim, J.J. Process for preparing powder comprising nanoparticles of sparingly soluble drug. WO2008013416 (2008).
37. Levy, M.-C., Andry, M.-C. Microcapsules with a wall of crosslinked plant polyphenols and compositions containing them. US5780060 (1998).
38. Malaknov, M.P., Fang, F. Technology for preparation of macromolecular microspheres. US20070190163 (2007).
39. Malakhov, M.P., Fang, F. Technology for the Preparation of microparticles. US20090098207 (2009).
40. Liu X, Sun Y, Zhang Y, Tang X. Preparation and in vitro-in vivo evaluation of silybin lipid microspheres. Asian J Pharm Sci 2007; 2: 204-10.
41. Van L., Bernhard H. Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles. US20026500463 (2002).
42. Van L., Bernhard H. Encapsulation of components into edible products. US20046723358 (2004).
43. Van, L., Bernhard, H. Encapsulation of sensitive liquid components into a matrix to obtain discrete shelf-stable particles. US20077201923 (2007).
44. Tournier, H., Hyacinthe, R., Schneider, M. Liposomal assembly for therapeutic and/or diagnostic use. US20070196284 (2007).
45. Suvanprakorn, P., Ploysangam, T., Tanasugarn, L., Chandrkra-chang, S., Zaias, N. Compositions and methods for administration of active agents using liposome beads. US0068365 (2003).
46. Suvanprakorn, P., Ploysangam, T., Tanasugarn, L., Chandr-krachang, S., Zaias, N. Topical application and methods for administration of active agents using liposome macro-beads. US20040224012 (2004).
47. Pillai, K., Costello, B., Oresajo, C., Ceccoli, J. Cosmetic compositions containing combinations of hydroxamate derivatives and antioxidants in a liposomal delivery system. US20060165641 (2006).
48. Woo JS, Kim T-S, Park J-H, Chi S-C. Formulation and biopharmaceutical evaluation of silymarin using SMEDDS. Arch Pharm Res 2007; 30: 82-9.
49. Jianming, C., Zhengliang, Y., Junfeng, X., Xiaoli, Z., Guangming, Z., Ying, Z. Hepadestal preparations and method for preparing the same. CN101112364 (2008).
50. Bezwada, R.S. Controlled release of biologically active compounds. US20090060979 (2009).
51. Grabowski, S., Rosenberg, J., Sanner, A. Slow-release matrix pellets and the production thereof. US20016290990 (2001).
52. Van, L., Bernhard, H. Embedding and encapsulation of controlled release particles. US20016190591 (2001).
53. Beisel, G. Composition with release-controlling action. US20036541031 (2003).
54. Soto, P., Claudia A. Pharmaceutical compound containing silymarin and carbopol, production method thereof and use of same as a regenerator of tissue and pancreatic cells with endogenous secretion damaged by diabetes mellitus. US20060041009 (2006).
55. Russell-J, G.J., Luke, M.R., Himes, S.R. Transdermal delivery of pharmaceutical agents. US20070243132 (2007).
56. Kanios, D.P., Gentile, J.A., Mantelle, J.A., Sablotsky, S. Compositions and methods for topical administration of pharmaceutically active agents. US5719197 (1998).
57. Kanios, D. Compositions and methods to effect the release profile in the transdermal administration of active agents. US6638528 (2003).
58. Kanios, D.P., Mantelle, J.A., Nguyen, V. Transdermal drug delivery device including an occlusive backing. US20060078604 (2006).
59. Festo, N. Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients. US20067026360 (2006).
60. Heather AEB. Transfersomes for transdermal drug delivery. Expert Opin Drug Deliv 2006; 3: 727-37.
61. Cevc, G. Preparation for the application of agents in mini-droplets. US20006165500 (2000).
62. Amey, J., Cade, D., Maes, P., Scott, R. Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process. US6245350 (2001).
63. Wang, X. Process for providing herbal medicants in cellulose derivative capsules. US0014351 (2001).
64. Wang, X. Process for providing herbal medicants in cellulose derivative capsules. US6238696 (2001).
65. Wang, X. Process for providing herbal medicants in cellulose derivative capsules. US6482432 (2002).
66. Gilinski, J. Flavored vegetarian cellulose capsule and methods for producing said capsule. US20060222699 (2006).
67. Goldman, D. Method of preparation of mixed phase co-crystals with active agents. US20050181041 (2005).
68. Di Pierro, F. Galactogenic compositions based on silymarin EP1774963 (2007).
69. Benesova, K., Cvak, L., Milan, S. Increased solubility flavanolignan preparations. US20087384919 (2008).
70. Gupta, S.K. Topical delivery of biological and cosmetic agents by zeolites US20090130154 (2009).
71. Koo, C.H., Lee, Y.C., Lee, H.S. Composition for protecting hepatocyte and liver containing silymarin and lipoic acid or its salts. KR0056032 (2005).
72. Papaconstantin, E., Lepage, P., Frerejouand, P., Marty, J.-P. Cosmetic and dermatological compositions including an extract of Silybum marianum rich in silymarine associated with essential fatty acids. US4997649 (1991).